Pregnancy outcomes of women who received conservative therapy for endometrial carcinoma or atypical endometrial hyperplasia

Pregnancy outcomes of women who received conservative therapy for endometrial carcinoma or atypical endometrial hyperplasia

Abstract Case Approximately 3%‐25% of cases of endometrial carcinoma (EC) or atypical endometrial hyperplasia (AH) occur in women aged <40 years and conservative treatment with high‐dose medroxyprogesterone acetate (MPA) is administered to women who wish to preserve their fertility. Here is repor...

Bibliografske podrobnosti
Main Authors:	Toshiya Matsuzaki, Takeshi Iwasa, Takako Kawakita, Yuri Yamamoto, Akiko Abe, Aki Hayashi, Kiyohito Yano, Masato Nishimura, Akira Kuwahara, Minoru Irahara
Format:	Article
Jezik:	English
Izdano:	Wiley 2018-07-01
Serija:	Reproductive Medicine and Biology
Teme:	assisted reproductive technology atypical endometrial hyperplasia conservative treatment endometrial carcinoma medroxyprogesterone acetate
Online dostop:	https://doi.org/10.1002/rmb2.12209

Podobne knjige/članki

Medroxyprogesterone Acetate Plus Metformin to Prevent Persistent Endometrial Hyperplasia
od: Vakkas Korkmaz, et al.
Izdano: (2013-08-01)

Results of surgical treatment of atypical endometrial hyperplasia
od: O. A. Gornykh, et al.
Izdano: (2014-07-01)

Modern approaches to the diagnosis of endometrial hyperplasia
od: M. M. Damirov, et al.
Izdano: (2025-02-01)

Microsatellite instability as a reliable marker of coexisting endometrial cancer in atypical endometrial hyperplasia
od: А. E. Protasova, et al.
Izdano: (2024-07-01)

Endometrial Atypical Hyperplasia and Risk of Endometrial Cancer
od: An-Ju Chou, et al.
Izdano: (2024-11-01)

Endometrial hyperplasia and progesterone resistance: a complex relationship
od: Mekan R. Orazov, et al.
Izdano: (2023-03-01)

The reproductive function of patients with prior atypical endometrial hyperplasia and endometrial cancer treatment: cohort study
od: Lana G. Dzhanashvili, et al.
Izdano: (2022-09-01)

Levonorgestrel-releasing intrauterine system (Mirena) in compare to medroxyprogesterone acetate as a therapy for endometrial hyperplasia
od: Fariba Behnamfar, et al.
Izdano: (2014-01-01)

Reproductive advance of fertility preservation in patients with early endometrial carcinoma or endometrial atypical hyperplasia
od: Jiao Yu, et al.
Izdano: (2022-12-01)

Laparoscopic surgery for atypical endometrial hyperplasia with awareness regarding the possibility of endometrial cancer
od: Misato Kamii, et al.
Izdano: (2023-01-01)

Features of the course of pregnancy and childbirth after conservative treatment of initial atypical hyperplasia and endometrial cancer
od: A. V. Charkhifalakyan, et al.
Izdano: (2025-01-01)

Conservative Management of Atypical Endometrial Hyperplasia and Early Endometrial Cancer in Childbearing Age Women
od: Stefano Uccella, et al.
Izdano: (2022-09-01)

The retrospective analysis results of the endometrial tissue pathological conditions development
od: V. V. Artyomenko, et al.
Izdano: (2020-11-01)

Recurrent endometrial atypical hyperplasia diagnosed by pathological examination of the placenta from a live birth: a case report
od: Weilu Wu, et al.
Izdano: (2023-09-01)

Prevalence of Co-existing Endometrial Carcinoma in Patients with Preoperative Diagnosis of Endometrial Hyperplasia
od: Pinar Kadirogullari, et al.
Izdano: (2015-10-01)

Diagnostic Value of ADC in Distinguishing Endometrial Cancer from Atypical Endometrial Hyperplasia and Within Molecular Subtypes
od: Xu S, et al.
Izdano: (2025-02-01)

Management of Recurrent Endometrial Cancer or Atypical Endometrial Hyperplasia Patients After Primary Fertility-Sparing Therapy
od: Junyu Chen, et al.
Izdano: (2021-09-01)

Liquid-based endometrial cytology associated with curettage in the investigation of endometrial carcinoma in postmenopausal women
od: Ke Ma, et al.
Izdano: (2016-12-01)

The present status of metformin in fertility-preserving treatment in atypical endometrial hyperplasia and endometrioid endometrial cancer
od: Jun Guan, et al.
Izdano: (2022-10-01)

Fertility-Sparing Treatment for Endometrial Cancer or Atypical Endometrial Hyperplasia Patients With Obesity
od: Junyu Chen, et al.
Izdano: (2022-02-01)

Clinical features and outcome of 15 patients with recurrent endometrial cancer or atypical endometrial hyperplasia received primary fertility-sparing therapy followed by hysterectomy
od: Yuanting Li, et al.
Izdano: (2021-03-01)

The proliferation markers in patients with different forms of hyperplastic endometrial processes
od: Yuri Krut, et al.
Izdano: (2022-05-01)

Correlation of plasma adipokines with endometrial atypical hyperplasia and type I/II endometrial cancer
od: Xinxin Zhu, et al.
Izdano: (2023-12-01)

Impacts of ovarian reserve on conservative treatment for endometrial cancer and atypical hyperplasia
od: Pengfei Wu, et al.
Izdano: (2024-01-01)

ENDOMETRIAL PRECANCER: DEFINITION OF CONCEPTS, TACTICS
od: Iu. Iu. Tabakman, et al.
Izdano: (2016-09-01)

Atypical Endometrial Hyperplasia and Unexpected Cancers at Final Histology: A Study on Endometrial Sampling Methods and Risk Factors
od: Luca Giannella, et al.
Izdano: (2020-07-01)

Fertility-sparing re-treatment for endometrial cancer and atypical endometrial hyperplasia patients with progestin-resistance: a retrospective analysis of 61 cases
od: Junyu Chen, et al.
Izdano: (2024-06-01)

Analysis of Factors Associated With Recurrence of Early-Stage Endometrial Carcinoma and Atypical Endometrial Hyperplasia in Infertile Women After In Vitro Fertilization Treatment
od: Yaxing Guo, et al.
Izdano: (2022-06-01)

Menopausal Status Combined with Serum CA125 Level Significantly Predicted Concurrent Endometrial Cancer in Women Diagnosed with Atypical Endometrial Hyperplasia before Surgery <sup>†</sup>
od: Yaochen Lou, et al.
Izdano: (2021-12-01)

Clinical, Sonographic, and Hysteroscopic Features of Endometrial Carcinoma Diagnosed after Hysterectomy in Patients with a Preoperative Diagnosis of Atypical Hyperplasia: A Single-Center Retrospective Study
od: Luca Pace, et al.
Izdano: (2022-12-01)

New classification system of endometrial hyperplasia WHO 2014 and its clinical implications
od: Katarzyna Sobczuk, et al.
Izdano: (2017-10-01)

Concurrent endometrial intraepithelial carcinoma (EIC) and endometrial hyperplasia
od: Steven Wang, MD, et al.
Izdano: (2015-03-01)

Age-related relationship between the development of hyperplastic processes and VEGF expression in endometrial cells
od: Z. V. Chumak, et al.
Izdano: (2020-04-01)

The incidence rates of endometrial hyperplasia and endometrial cancer: a four-year population-based study
od: Jin-Sung Yuk
Izdano: (2016-08-01)

Non-atypical endometrial hyperplasia: risk factors for occult endometrial atypia and malignancy in patients managed with hysterectomy
od: Lee Shi Hui, et al.
Izdano: (2021-05-01)

Effects of isoflavone supplementation on endometrial thickness, endometrial hyperplasia, and cancer in ovariectomized cats
od: Mona Negadmonfared, et al.
Izdano: (2022-01-01)

Atypical Endometrial Hyperplasia Arising in a Cesarean Section Scar: A Mechanism of Malignant Transformation
od: Marta Monist, et al.
Izdano: (2019-04-01)

Comparative effects of progestin-based combination therapy for endometrial cancer or atypical endometrial hyperplasia: a systematic review and network meta-analysis
od: Jie Cui, et al.
Izdano: (2024-05-01)

Hyperplasia and endometrial precancer
od: O. A. Gornikh, et al.
Izdano: (2014-08-01)

Current research of Assisted Reproductive Technology for women with early endometrial cancer and atypical endometrial hyperplasia after conservative treatment
od: Yan-le Jiang, et al.
Izdano: (2024-06-01)